NeuroPace

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.

Our mission is to develop innovative treatments and therapies that help improve the lives of patients with neurological disorders. We strive to provide the best possible care and promote positive outcomes for our patients.

Our vision is to be the world's leading provider of improved treatments, therapies, and devices for neurological disorders.

Since its founding, NeuroPace has earned numerous awards and recognitions, including being named one of the Most Innovative Companies in Healthcare by Fast Company and The Museum of Modern Art. In addition, NeuroPace has won multiple awards from The Wall Street Journal, including Most Innovative Medical Technologies and Best Personal Health Solutions.